Skip to main content
Fig. 3 | BMC Biotechnology

Fig. 3

From: Development of a luciferase/luciferin cell proliferation (XenoLuc) assay for real-time measurements of Gfp-Luc2-modified cells in a co-culture system

Fig. 3

Inhibition of NPC xenograft cell viability by cisplatin as measured by XenoLuc assay. Xenograft cells (1 × 104 cells/well) were seeded onto 96-well plates (a: 2D model; b: 3D model) and treated with various concentrations of cisplatin as described in Methods. Luciferase activities were measured at Day 3. Results are represented by average of triplicate from 3 mice ± SD

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us